232 related articles for article (PubMed ID: 18555841)
1. Hepatic steatosis rather than visceral adiposity is more closely associated with insulin resistance in the early stage of obesity.
Wasada T; Kasahara T; Wada J; Jimba S; Fujimaki R; Nakagami T; Iwamoto Y
Metabolism; 2008 Jul; 57(7):980-5. PubMed ID: 18555841
[TBL] [Abstract][Full Text] [Related]
2. Effect of 6-month nutritional intervention on non-alcoholic fatty liver disease.
Elias MC; Parise ER; de Carvalho L; Szejnfeld D; Netto JP
Nutrition; 2010; 26(11-12):1094-9. PubMed ID: 20022466
[TBL] [Abstract][Full Text] [Related]
3. Surrogate markers of visceral adiposity in young adults: waist circumference and body mass index are more accurate than waist hip ratio, model of adipose distribution and visceral adiposity index.
Borruel S; Moltó JF; Alpañés M; Fernández-Durán E; Álvarez-Blasco F; Luque-Ramírez M; Escobar-Morreale HF
PLoS One; 2014; 9(12):e114112. PubMed ID: 25479351
[TBL] [Abstract][Full Text] [Related]
4. Serum concentration of adiponectin, leptin and resistin in obese children with non-alcoholic fatty liver disease.
Lebensztejn DM; Wojtkowska M; Skiba E; Werpachowska I; Tobolczyk J; Kaczmarski M
Adv Med Sci; 2009; 54(2):177-82. PubMed ID: 20022856
[TBL] [Abstract][Full Text] [Related]
5. Hepatic steatosis in obese Chinese children.
Chan DF; Li AM; Chu WC; Chan MH; Wong EM; Liu EK; Chan IH; Yin J; Lam CW; Fok TF; Nelson EA
Int J Obes Relat Metab Disord; 2004 Oct; 28(10):1257-63. PubMed ID: 15278103
[TBL] [Abstract][Full Text] [Related]
6. Relationships between estimates of adiposity, insulin resistance, and nonalcoholic fatty liver disease in a large group of nondiabetic Korean adults.
Sung KC; Ryan MC; Kim BS; Cho YK; Kim BI; Reaven GM
Diabetes Care; 2007 Aug; 30(8):2113-8. PubMed ID: 17475935
[TBL] [Abstract][Full Text] [Related]
7. [Fatty liver disease, insulin resistance and adiponectin in an obese pediatric population].
López-Capapé M; López-Bermejo A; Alonso Blanco M; Lara Orejas E; Corbatón Blasco J; Barrio Castellanos R
An Pediatr (Barc); 2009 Dec; 71(6):495-501. PubMed ID: 19850541
[TBL] [Abstract][Full Text] [Related]
8. Ultrasonographic and biochemical evaluation of visceral obesity in obese women with non-alcoholic fatty liver disease.
Fenkci S; Rota S; Sabir N; Akdag B
Eur J Med Res; 2007 Feb; 12(2):68-73. PubMed ID: 17369120
[TBL] [Abstract][Full Text] [Related]
9. [Insulin-like growth factor-binding protein-1: a new biochemical marker of nonalcoholic fatty liver disease?].
Graffigna MN; Belli SH; de Larrañaga G; Fainboim H; Estepo C; Peres S; García N; Levalle O
Acta Gastroenterol Latinoam; 2009 Mar; 39(1):30-7. PubMed ID: 19408737
[TBL] [Abstract][Full Text] [Related]
10. Body adiposity index and other indexes of body composition in the SAPHIR study: association with cardiovascular risk factors.
Melmer A; Lamina C; Tschoner A; Ress C; Kaser S; Laimer M; Sandhofer A; Paulweber B; Ebenbichler CF
Obesity (Silver Spring); 2013 Apr; 21(4):775-81. PubMed ID: 23712981
[TBL] [Abstract][Full Text] [Related]
11. Hepatic steatosis, visceral adiposity, insulin resistance, adiponectin, and inflammation.
Tasci I; Erdem G; Sonmez A; Dogru T; Ercin CN
Metabolism; 2009 Jan; 58(1):141; author reply 142. PubMed ID: 19059541
[No Abstract] [Full Text] [Related]
12. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
13. Insulin Resistance but Not Visceral Adiposity Index Is Associated with Liver Fibrosis in Nondiabetic Subjects with Nonalcoholic Fatty Liver Disease.
Ercin CN; Dogru T; Genc H; Celebi G; Aslan F; Gurel H; Kara M; Sertoglu E; Tapan S; Bagci S; Rizzo M; Sonmez A
Metab Syndr Relat Disord; 2015 Sep; 13(7):319-25. PubMed ID: 26011302
[TBL] [Abstract][Full Text] [Related]
14. Decreased plasma adiponectin concentrations are closely associated with nonalcoholic hepatic steatosis in obese individuals.
Targher G; Bertolini L; Scala L; Poli F; Zenari L; Falezza G
Clin Endocrinol (Oxf); 2004 Dec; 61(6):700-3. PubMed ID: 15579183
[TBL] [Abstract][Full Text] [Related]
15. The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents.
Masquio DC; de Piano A; Campos RM; Sanches PL; Carnier J; Corgosinho FC; Netto BD; Carvalho-Ferreira JP; Oyama LM; Nascimento CM; de Mello MT; Tufik S; Dâmaso AR
Br J Nutr; 2015 Jun; 113(12):1920-30. PubMed ID: 25907896
[TBL] [Abstract][Full Text] [Related]
16. Adiponectin, body mass index and hepatic steatosis are independently associated with IGF-I status in obese non-diabetic women.
Sirbu A; Gologan S; Arbanas T; Copaescu C; Martin S; Albu A; Barbu C; Pirvulescu I; Fica S
Growth Horm IGF Res; 2013; 23(1-2):2-7. PubMed ID: 23111188
[TBL] [Abstract][Full Text] [Related]
17. The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease.
Oh SY; Cho YK; Kang MS; Yoo TW; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Son BH; Shin JH
Metabolism; 2006 Dec; 55(12):1604-9. PubMed ID: 17142131
[TBL] [Abstract][Full Text] [Related]
18. Mesenteric fat thickness as an independent determinant of fatty liver.
Liu KH; Chan YL; Chan JC; Chan WB; Kong WL
Int J Obes (Lond); 2006 May; 30(5):787-93. PubMed ID: 16418763
[TBL] [Abstract][Full Text] [Related]
19. Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease.
Ayonrinde OT; Olynyk JK; Beilin LJ; Mori TA; Pennell CE; de Klerk N; Oddy WH; Shipman P; Adams LA
Hepatology; 2011 Mar; 53(3):800-9. PubMed ID: 21374659
[TBL] [Abstract][Full Text] [Related]
20. Liver steatosis in obese prepubertal children: a possible role of insulin resistance.
D'Adamo E; Impicciatore M; Capanna R; Loredana Marcovecchio M; Masuccio FG; Chiarelli F; Mohn AA
Obesity (Silver Spring); 2008 Mar; 16(3):677-83. PubMed ID: 18239582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
